Product details
              WHO Product ID
              WHOAPI-139
          Status
              Prequalified
          Date of prequalification
              Basis of listing
              Prequalification - Standard
          Therapeutic area
          HIV/AIDS
              Grade
              Standard
          INN
              Emtricitabine
          Confirmation of WHO API prequalification document (version date) 
              Applicant organization
              Laurus Labs Limited
    
            2nd Floor, Serene Chambers, Road No. 7, Banjara Hills
      
              
        
        Hyderabad,
        Telangana
      
            500 034
      
            India
      
      APIMF Version Number
              LL/EMTRICITABINE/OP/02/AUGUST-2018
LL/EMTRICITABINE/RP/02/AUGUST-2018
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-1/February-2019
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-1/February-2019
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-2/August-2021
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-2/August-2021
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-3/April-2022
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-3/April-2022
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-4/December-2022
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-4/December-2022
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-5/April-2023
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-5/April-2023
LL/EMTRICITABINE/OP/02/AUGUST-2018/ mend-6/July-2024
LL/EMTRICITABINE/RP/02/AUGUST-2018/ mend-6/July-2024
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-7/Sept-2024
      
      LL/EMTRICITABINE/RP/02/AUGUST-2018
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-1/February-2019
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-1/February-2019
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-2/August-2021
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-2/August-2021
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-3/April-2022
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-3/April-2022
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-4/December-2022
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-4/December-2022
LL/EMTRICITABINE/OP/02/AUGUST-2018/Amend-5/April-2023
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-5/April-2023
LL/EMTRICITABINE/OP/02/AUGUST-2018/ mend-6/July-2024
LL/EMTRICITABINE/RP/02/AUGUST-2018/ mend-6/July-2024
LL/EMTRICITABINE/RP/02/AUGUST-2018/Amend-7/Sept-2024
Product Grades
              API specification number
              FS/AECB/02 version 9
          Storage condition
              Do not store above 30°C, protect from moisture
          Storage period (months)
              48
          Duration type
              Retest period
          Packaging
              Double transparent LDPE bags housed within HDPE drums
          API Manufacturing Site(s)
  Laurus Labs Limited
      
            Unit 3, Plot No 18, Jawaharlal Nehru Pharma City,  Parawada
      
              
        
        Anakapalli,
        Andhra Pradesh
      
            531 021
      
            India